Protalix Drug in Phase IIa Study for Gaucher Disease – Analyst Blog
Protalix BioTherapeutics, Inc. ( PLX ) announced that it has enrolled the first patient in a 28 day open label, …read more
Protalix BioTherapeutics, Inc. ( PLX ) announced that it has enrolled the first patient in a 28 day open label, …read more
On Jun 18, we have issued an updated research report on Pinnacle West Capital Corp. ( PNW ). The utility …read more
United Technologies Corp. ( UTX ) declared that its segment Sikorsky Aircraft Corp. has amended a contract agreement with the …read more
Industrial gas producer and supplier, Praxair Inc. ( PX ) started a new plant yesterday for supplying oxygen at the …read more
Watch Tracey Ryniec in a flash update discuss the pros and cons of the New Fire Phone from Amazon (AMZN). …read more
Merck KGaA ( MKGAF ) has decided to terminate its license agreement with Ono Pharmaceutical Co., Ltd. ( OPHLF ) …read more
Ford Motor Co. ( F ) reported a 0.9% dip in May sales in Europe to 98,600 units. The automaker …read more
Fifth Third Bancorp ( FITB ) has announced a cash dividend of 13 cents per common share for second quarter …read more
Campbell Soup Company ( CPB ) recently elected Marc B. Lautenbach as a new director of its management board effective …read more
Today, we’re bringing you an article about energy stocks and the trouble they may run into. Here’s a quote, “energy stocks may be getting too… Read More »Energy Stocks May Have Problems Ahead